Valuation Outlook Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			5-day change	1st Jan Change
1.450 ^USD	-1.36%		-15.20%	-8.23%

06-16	Outlook Therapeutics Shares Surge After FDA Accepts Resubmitted Wet AMD Application	DJ
06-16	Outlook Therapeutics, Inc. Announces FDA Acceptance Of Resubmitted Biologics License Application For ONS-5010/LYTENAVA (Bevacizumab-Vikg) As A Treatment For Wet AMD	CI

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	380.5	275.9	57.51	126.3	47.08	175.3	-	-
Change	-	-27.49%	-79.15%	119.63%	-62.73%	272.21%	-	-
Enterprise Value (EV)	380.5	275.9	57.51	126.3	47.08	175.3	175.3	175.3
Change	-	-27.49%	-79.15%	119.63%	-62.73%	272.21%	0%	0%
P/E	-6.2x	-3.94x	-0.92x	-1.32x	-0.59x	-2.96x	-4.83x	-9.67x
PBR	71.9x	29.6x	-	-	-	-	-	-
PEG	-	0.3x	0x	0.1x	0x	0x	0.1x	0.2x
Capitalization / Revenue	-	-	-	-	33.3x	146x	3.83x	7.67x
EV / Revenue	-	-	-	-	0x	146x	3.83x	7.67x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-3.52x	-5.29x	-11.5x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7	-6.2	-4.8	-4.06	-1.79	-0.49	-0.3	-0.15
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	1.413	1.2	45.73	22.84
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-51.73	-63.07	-53.13	-71.7	-67.06	-49.75	-33.11	-15.3
Net income ¹	-53.16	-66.05	-58.98	-75.37	-62.42	-52.18	-42.33	-14.53
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	43.400	24.400	4.420	5.340	1.060	1.450	1.450	1.450
Nbr of stocks (in thousands)	8,767	11,307	13,012	23,656	44,420	120,863	-	-
Announcement Date	12/22/21	12/29/22	12/22/23	12/27/24	12/19/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
OUTLOOK THERAPEUTICS, INC.	-2.96x	-	-	-	175M
LONZA GROUP AG	34.6x	6.07x	18.79x	0.95%	49.92B
REVOLUTION MEDICINES, INC.	-23.69x	348.89x	-22.4x	-.--%	40.23B
IQVIA HOLDINGS INC.	25.19x	2.79x	12.06x	-.--%	34.55B
BEONE MEDICINES AG	44.97x	4.49x	28.67x	-.--%	33.09B
CELLTRION, INC.	30.52x	8.33x	21.46x	0.41%	27.51B
MEDPACE HOLDINGS, INC.	32.72x	5.32x	24.23x	-.--%	15.92B
EUROFINS SCIENTIFIC SE	24.09x	2.05x	9x	1.11%	13.86B
IONIS PHARMACEUTICALS, INC.	-22.69x	14.88x	-22.26x	-.--%	13.52B
Average	15.86x	49.10x	8.69x	0.31%	25.42B
Weighted average by Cap.	19.76x	66.17x	9.63x	0.32%